Skip to main content
Premium Trial:

Request an Annual Quote

Donald Huffman, Elias Caro

Premium
Guava Technologies this week announced the appointment of Donald Huffman as chief financial officer.
 
Huffman most recently served as CFO and principal of Sanderling Ventures, a biomedical venture capital firm. He has also served as CFO for Genteric, Microcide Pharmaceuticals, Celtrix Pharmaceuticals, and medical device company EndoSonics. He holds a BS from Pennsylvania State University and an MBA from the State University of New York at Buffalo.
 

 
Elias Caro, executive vice president of international diagnostics and global life sciences commercial operations at Beckman Coulter, retired effective July 31, according to an 8-K filing with the US Securities and Exchange Commission.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.